Kenan Turnacioglu
General Partner · Catalio Capital Management
Kenan Turnacioglu, Ph.D., is a biotech investor focused on healthcare and AI-driven biomedical solutions, investing primarily in life sciences companies developing next-generation drugs, devices, diagnostics, and data tools [2][10]. As a former General Partner at Catalio Capital Management, he supports companies across all stages from inception to IPO, with the firm targeting deals of
